NL-OMON47473已完成4 期
Contrast Medium Reduction with AlluraClarity for Iliac/Peripheral and EVAR procedures - Contrast Medium Reduction with AlluraClarity (COMER)
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Philips
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* Subject will be undergoing an EVAR or iliac/peripheral procedure
- •* Subject is 18 years of age or older
排除标准
- •* Subject with contrast allergies
- •* Subject with severe kidney disease (e-GFR<45, determined by the MDRD formula)
- •* Subject participates in a potentially confounding drug or device trial during the course of the study.
- •* Subject meets an exclusion criteria according to national law (e.g. age, pregnant woman, breast feeding woman)
- •* Subject with overt hyperthyroidism
研究者
相似试验
尚未招募
不适用
Contrast Medium Reduction with AlluraClarity for Alliac/Peripheral and EVAR proceduresEndovascular ProceduresAbdominal AneurysmNL-OMON25607Philips Medical Systems Nederland B.V.Veenpluis 4-6 5684 PC Best The Netherlands260
已完成
不适用
Reducing the amount of contrast medium in CTAs of the abdominal aorta using a multiphasic injection technique and a test bolus to reduce the bolus volumeBloodvessel deviations10003216NL-OMON35570Jeroen Bosch Ziekenhuis30
招募中
不适用
Reducing the amount of contrast medium in CTAs of the abdominal aorta using a multiphasic injection techniqueBloodvessel deviations10003216NL-OMON35498Jeroen Bosch Ziekenhuis30
招募中
Unknown
Dual-Energy CTA with High-Concentration Contrast MaterialJPRN-jRCTs041230098oda Yoshifumi100
招募中
3 期
The effect of contrast agent reduction on the image quality of pulmonary Computed Tomographypulmonary thromboembolism.Pulmonary embolismIRCT20220313054273N2Shiraz University of Medical Sciences40